All In Biotech

Drug Trial Radar · NCT01575834

Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

A Multicenter, International, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

Last checked: Nov 20, 2026Latest source record: Aug 28, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 7,180 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

7,180

Actual

Start

Mar 15, 2012

Primary completion

Dec 14, 2015

Study completion Dec 28, 2016

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Apr 12, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 55 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if treatment with romosozumab is effective in preventing fractures in women with postmenopausal osteoporosis

Conditions

  • Postmenopausal Osteoporosis

Interventions

  • RomosozumabDrug

    Administered by subcutaneous injection once a month (QM)

  • PlaceboDrug

    Administered by subcutaneous injection once a month (QM)

  • DenosumabDrug

    Administered by subcutaneous injection once every 6 months (Q6M)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With New Vertebral Fracture Through Month 12Time frame: 12 Months
  2. Percentage of Participants With New Vertebral Fracture Through Month 24Time frame: 24 months

Locations

218 sites in 24 countries. Site status is shown where the registry gives one.

  • Research Site

    Tucson, Arizona

  • Research Site

    Laguna Hills, California

  • Research Site

    Los Angeles, California

  • Research Site

    Sacramento, California

  • Research Site

    Santa Maria, California

  • Research Site

    Walnut Creek, California

  • Research Site

    Lakewood, Colorado

  • Research Site

    Leesburg, Florida

  • Research Site

    Palm Harbor, Florida

  • Research Site

    Plantation, Florida

  • Research Site

    Tampa, Florida

  • Research Site

    Gainesville, Georgia

  • Research Site

    New Orleans, Louisiana

  • Research Site

    Bethesda, Maryland

  • Research Site

    Boston, Massachusetts

  • Research Site

    Detroit, Michigan

  • Research Site

    Albuquerque, New Mexico

  • Research Site

    Asheville, North Carolina

  • Research Site

    Fargo, North Dakota

  • Research Site

    Cincinnati, Ohio

  • Research Site

    Mayfield, Ohio

  • Research Site

    Duncansville, Pennsylvania

  • Research Site

    Denton, Texas

  • Research Site

    Richmond, Virginia

  • Research Site

    Madison, Wisconsin

  • Research Site

    Buenos Aires, Argentina

  • Research Site

    Buenos Aires, Argentina

  • Research Site

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Research Site

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Research Site

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Research Site

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • Research Site

    Mar del Plata, Buenos Aires, Argentina

  • Research Site

    Córdoba, Córdoba Province, Argentina

  • Research Site

    Maroubra, New South Wales, Australia

  • Research Site

    St Leonards, New South Wales, Australia

  • Research Site

    Herston, Queensland, Australia

  • Research Site

    Keswick, South Australia, Australia

  • Research Site

    Footscray, Victoria, Australia

  • Research Site

    Geelong, Victoria, Australia

  • Research Site

    Heidelberg West, Victoria, Australia

Showing 40 of 218 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.